Skip to main content
Denmark
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkter
  • Om os
  • Nyheder
  • Instrument service
  • Antimicrobial resistance
  • Messer og udstillinger
  • Aidian Academy
  • Kunde historier
Kontakt os Søg
Logo
Kontakt os
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Point of care
  • QuikRead go-systemet
  • microINR
  • Certest
  • FACIT
  • SD BIOSENSOR STANDARD F
  • bioLytical Laboratories INSTI®
  • Nova Biomedical
  • ACRO™ Biotech
  • Hangzhou AllTest Biotech
Læs mere
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go tilbehør
QuikRead go
Mikrobiologi
  • Uricult / Uricult Trio-tests
  • Uricult Vet
  • Cultura M
  • MIKROGEN serologi
  • Meridian Immunoassays
  • Meridian Curian®
  • Reagena
Læs mere
Molekylær mikrobiologi
  • Meridian Revogene®
  • Meridian Alethia®
  • MIKROGEN molecular diagnostics
  • SD BIOSENSOR STANDARD M10
Læs mere
Hygiejneovervågning
  • Easicult
  • Hygicult
  • Clean Card PRO
Læs mere
RIA / Collagener
  • UniQ RIA
Læs mere
Andre
  • Grifols Promonitor®
Læs mere
  • Aidian i Danmark
  • Bestyrelse og direktion
  • Bæredygtighed
  • Kultur
  • Karriere
  • Nyheder
  • Produktnyheder
  • AMR
  • Begivenheder
  • Stories from customers
  • COVID-19
  • Om C-reaktivt protein (CRP)
  • CRP and lower respiratory tract infections
  • Understøttende materialer
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Generally
  • Product information
  • Documents and materials
  • Frequently asked questions
  • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Logo
Kontakt os Tæt
  • Produkter
    • Point of care
      • QuikRead go-systemet
      • microINR
      • Certest
      • FACIT
      • SD BIOSENSOR STANDARD F
      • bioLytical Laboratories INSTI®
      • Nova Biomedical
      • ACRO™ Biotech
      • Hangzhou AllTest Biotech
    • Mikrobiologi
      • Uricult / Uricult Trio-tests
      • Uricult Vet
      • Cultura M
      • MIKROGEN serologi
      • Meridian Immunoassays
      • Meridian Curian®
      • Reagena
    • Molekylær mikrobiologi
      • Meridian Revogene®
      • Meridian Alethia®
      • MIKROGEN molecular diagnostics
      • SD BIOSENSOR STANDARD M10
    • Hygiejneovervågning
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagener
      • UniQ RIA
    • Luftvejsinfektioner
    • Andre
      • Grifols Promonitor®
  • Om os
    • Aidian i Danmark
    • Bestyrelse og direktion
    • Bæredygtighed
    • Kultur
    • Karriere
  • Nyheder
    • Nyheder
    • Produktnyheder
    • AMR
    • Begivenheder
    • Stories from customers
    • COVID-19
  • Instrument service
  • Antimicrobial resistance
    • Om C-reaktivt protein (CRP)
    • CRP and lower respiratory tract infections
    • Understøttende materialer
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Messer og udstillinger
  • Aidian Academy
    • Generally
    • Product information
    • Documents and materials
    • Frequently asked questions
  • Kunde historier
    • Sovehygiejne: overvågning af renlighed af puder og sengetøj
Populære produkter
AllTest hCG hurtig test

AllTest hCG hurtig test

AllTest MONO hurtig test

AllTest MONO hurtig test

Acro Strep A hurtig test

Acro Strep A hurtig test

Seneste nyt
Se alt

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Increase in influenza and RSV activity in the EU/EEA

14. januar 2025 | Nyheder

  • Se alt
  • Ingen resultater fundet
  • Loading...
Nyheder

Are you prepared for tick season?

9. april 2025 | Nyheder, Produktnyheder

Vi præsenterer QuikRead go Plus Instrument!

20. januar 2025 | Nyheder, Produktnyheder

Tilbage til alle nyheder
24. november 2021
Nyheder,
Produktnyheder,
AMR

Implementation of QuikRead go CRP POC testing in nursing homes benefits the residents and helps to combat antimicrobial resistance

Overprescribing of antibiotics is common in nursing homes

Antibiotic overprescribing in lower respiratory tract infections (LRTIs) is common in nursing homes because patients may have atypical clinical presentations. Also, the lack of diagnostic options make diagnosis often difficult, and differentiation of severe and self-limiting infections is challenging. Nursing home residents may be fragile, and infections have a high risk to have serious outcomes. Therefore, antibiotics are often prescribed just in case to avoid any risk for the residents. Antimicrobial resistance (AMR) is an emerging health threat and rationalizing antibiotic use in all healthcare settings is important to decelerate the development of ARM.

The UPCARE study investigated the effect and implementation of CRP point of care in nursing homes

C-reactive protein (CRP) point of care testing (POCT) has shown to decrease unnecessary antibiotic prescribing in LRTIs in primary care. Nevertheless, the evidence from the nursing home setting has been lacking. The UPCARE study in the Netherlands (Using Point-of-care C-reactive protein to Guide Antibiotic Prescribing for Respiratory Tract Infections in Elderly Nursing Home Residents) used QuikRead go CRP POCT and investigated the effect of CRP POCT for antibiotic prescribing in nursing homes1. The study also conducted a process evaluation about the implementation of CRP POCT in nursing home facilities and assessed the barriers and facilitators for the use of CRP POCT2.

The implementation of CRP POCT in nursing homes decrease unnecessary antibiotic prescribing for lower respiratory tract infections

The UPCARE study demonstrated that CRP POCT decreased antibiotic prescribing for LRTIs by 29 % compared to usual care without increasing the number of hospitalizations, mortality or affecting patient's recovery1. Furthermore, physicians who participated in the study felt that the use of CRP POCT was one of the main factors that changed their antibiotic prescribing behaviour for LRTIs during the study period2. These findings support the idea that large-scale implementation of CRP POCT is useful in nursing homes and aids the management of LRTI’s.

Easy access to the analyzer and good communication between the personnel facilitate successful CRP POC implementation

Adoption of new interventions in nursing homes can be challenging because patients are heterogenic, and the nursing home setting may be complex. To support the use of CRP POCT in a nursing home setting, authors provided key recommendations for CRP implementation in the nursing home setting2:

  • Implementation of CRP POCT is recommended in medium to large nursing homes with >75 residents.
  • Cooperate with a primary care laboratory.
  • Appoint 1-2 team champions per location for medical training (physician) and management of the POCT user group (physician or a nurse).
  • POCT group should be manageable and proportional to the number of residents.
  • POCT analyzer and materials needed for testing should be within a short distance.
  • Short line communication is important between personnel involved with CRP POCT.
  • Exchange of experiences regarding CRP POCT during team meetings.

As seen in the UPCARE study, implementations of new interventions, such as CRP POCT, may provide substantial benefits for nursing home residents.1,2 Reduction of unnecessary antibiotic prescribing decrease the unnecessary medication of the residents and possible adverse events of the antibiotics. Also, rational antibiotic prescribing helps to fight against the global threat of antimicrobial resistance.


References

  1. Boere TM, van Buul LW, Hopstaken RM et al. Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial. BMJ 2021; 374:n2198.
  2. Boere TM, Hopstaken RM, van Tulder MW et al. Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes. JAMDA 2021, in press https://doi.org/10.1016/j.jamda.2021.09.010
Share
Facebook
Twitter
E-mail

Aidian Denmark ApS

Ørestads Boulevard 73,
2300 København S


+45 8610 3020


Forespørgsler
info@aidian.dk


Salg
order@aidian.dk

Selskab
  • Om os
  • Bæredygtighed
  • Karriere
  • Kontakt os
Produkter
  • Point of care
  • Mikrobiologi
  • Molekylær mikrobiologi
  • Hygiejneovervågning
  • RIA / Collagener
  • Luftvejsinfektioner
  • Andre
Hurtige links
  • Aidian Academy
Copyright © 2025 Aidian
  • Persondatapolitik
  • Erklæring om beskyttelse af persondata
  • Cookie-politik
  • Sociale medier politik